In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine.
Specifically, Dr. Gibbin-Lameira will show that:
- Dose-dependent experiments can be performed in 96-well plate format over long periods of time (> 2 days), reducing the need for time and labor-intensive multiple fixed-point measurements and eliminating cytotoxic/cytostatic effects arising from the use of labels, dyes, or phototoxic damage
- Metrics output from Nanolive’s proprietary software, EVE Analytics, can be used to generate statistically robust time-dependent EC50 values based on total dry mass; a metric unique to label-free imaging
- Sub-cellular spatial resolution combined with high content image analysis can be used to investigate a drugs’ mechanism of action
Please register below to watch the webinar on-demand.
Read our latest news
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.
Online walkthrough – Replace fragmented assays: one workflow for cell therapy assessment
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.
Ferroptosis and CAR-T Engineering: Research from MIT
Discover live cell imaging data highlights from a seminar at MIT and register for Nanolive’s latest data walkthrough for liquid tumor analysis.